Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06539936 · ClinicalTrials.gov registry record · NA
Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses
A NA study of Amputation and Upper Limb, sponsored by Infinite Biomedical Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT06539936 is a NA study of Amputation and Upper Limb that is actively recruiting participants, run by Infinite Biomedical Technologies. The registered enrollment target is 7 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06539936, a NA study of Amputation and Upper Limb, is actively recruiting participants, sponsored by Infinite Biomedical Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will test the following hypothesis: Use of Glide results in improved functional performance, satisfaction, and usage metrics as compared to use of a standard Direct Control (DC) prosthesis. This study will compare the use of Glide \[Experimental\] prosthesis with a DC \[Standard\] prosthesis in a clinical setting and in unsupervised daily activity. We will follow a multiple baseline design, specifically an AB design. Each of the subjects will use the Experimental and Standard systems over a total of 24-weeks. The A phase is the baseline phase where the DC prosthesis will be used, and the B phase will be the treatment phase where the Glide prosthesis will be used. Participants will undergo an A phase of either 10-weeks, 12-weeks, or 14-weeks duration, with the remaining 14-, 12-, or 10-weeks of the study being dedicated to the B phase.
Conditions Studied
Interventions
- DEVICE Glide
- DEVICE Direct Control
Study Locations (1)
California
- Advanced Arm Dynamics - Redondo Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06539936
The ClinicalTrials.gov registry entry for NCT06539936 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (95% lower). The listed sponsor is Infinite Biomedical Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Glide is the first listed.
NCT06539936 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06539936 about?
NCT06539936 is a clinical study titled "Regulatory Clearance of the Glide Control Strategy for Upper Limb Prostheses". The investigators will test the following hypothesis: Use of Glide results in improved functional performance, satisfaction, and usage metrics as compared to use of a standard Direct Control (DC) prosthesis. This study will compare the use of Glide \[Experimental\] prosthesis with a DC \[Standard\]...
What is the current status of trial NCT06539936?
This trial is currently recruiting. It is a NA study. The enrollment target is 7 participants. The study started on 2024-09-16. Estimated completion is 2026-03-31.
What conditions does trial NCT06539936 study?
This clinical trial studies the following conditions: Amputation, Upper Limb.
What interventions are being tested in trial NCT06539936?
The interventions under investigation include: Glide (DEVICE), Direct Control (DEVICE).
Who is sponsoring clinical trial NCT06539936?
This trial is sponsored by Infinite Biomedical Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06539936 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amputation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Myoelectric Implantable Recording Array (MIRA) in Participants With Transradial Amputation
RECRUITING · NA
-
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment
RECRUITING · NA
-
Hand Transplantation
RECRUITING · NA
-
Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation
RECRUITING · NA
-
Can an Array of Micro-electrodes Implanted in a Human Nerve Record Neural Signals and Provide Feedback?
RECRUITING · NA
-
Intuitive Control of a Hybrid Prosthetic Leg During Ambulation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.